BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 2482293)

  • 1. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
    Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
    Donato NJ; Yan DH; Hung MC; Rosenblum MG
    Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
    Donato NJ; Rosenblum MG; Steck PA
    Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferation.
    Nishikawa K; Rotbein J; Vijjeswarapu D; Owen-Schaub L; Rosenblum MG; Donato NJ
    Lymphokine Cytokine Res; 1994 Feb; 13(1):37-45. PubMed ID: 8186323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
    Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
    Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
    Perez M; Haschke B; Donato NJ
    Oncogene; 1999 Jan; 18(4):967-78. PubMed ID: 10023672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
    Hauguel-DeMouzon S; Csermely P; Zoppini G; Kahn CR
    J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
    Gulli LF; Palmer KC; Chen YQ; Reddy KB
    Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
    Mishra S; Mathur R; Hamburger AW
    Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.
    Donato NJ; Rotbein J; Rosenblum MG
    J Cell Biochem; 1991 May; 46(1):69-77. PubMed ID: 1874802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.
    Bird TA; Saklatvala J
    J Immunol; 1989 Jan; 142(1):126-33. PubMed ID: 2783320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
    Chen Q; DeFrances MC; Zarnegar R
    Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells.
    Mawatari M; Kohno K; Mizoguchi H; Matsuda T; Asoh K; Van Damme J; Welgus HG; Kuwano M
    J Immunol; 1989 Sep; 143(5):1619-27. PubMed ID: 2547871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.
    Donato NJ; Gallick GE; Steck PA; Rosenblum MG
    J Biol Chem; 1989 Dec; 264(34):20474-81. PubMed ID: 2555361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT
    Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.